Anfisa receives new threats and requests an immediate investigation

Those same orders were actually issued in November. (Photo: Marcelo Camargo/Aigncia Brasil)

On Sunday noon (12/19), Anvisa (National Health Monitoring Agency) reported that it had received new threats due to the decision approving the application of vaccines against COVID-19 in children. According to the regulator, “the growth of threats makes it necessary to conduct further investigations to identify the authors and establish responsibilities.”

In an official note, Anvisa reiterates police protection requests for its members. These same requests were already made in November, when the first attacks arrived.

The agency explained that it “does not publish the attachments that embody the incoming threats so as not to reveal the personal data of those involved, but all the information has been sent to the responsible authorities.”

President Bolsonaro

President Jair Bolsonaro (PL) used the day off to take a boat ride in Guaruj on Sunday (12/19). Then the CEO was Praia Grande, where he greeted and took selfies with his supporters. To a man who asked him about the vaccination in children, the president criticized the agency’s decision and replied that it was “unbelievable what Anfisa has done.”

The CEO said in a video: “We are working. Nor your mandatory freedom. It is very dangerous. It is not known about the possible negative effects in the future. It is incredible, sorry here, what Anvisa did. Unbelievable” posted on social networks.

On the 16th day, the regulator approved the application of a vaccine against covid-19 by Pfizer to children between the ages of 5 and 11 years.

Speaking live on the 16th, Bolsonaro said he asked, informally, “the names of people who have approved the vaccine for children aged five and over.”

“We want to publish the names of these people so that everyone knows who these people are, and their verdict is clearly given,” he said at the appointment.

According to Anfisa, the technical field concluded that the benefits of the vaccine outweigh the risks. During a press conference to announce the approval of a children’s vaccine, representatives of Brazilian medical associations supported Anvisa’s decision.